In pathological conditions, such as AD, tau alterations are associated with synapse dysfunction, neuronal degeneration, and cognitive decline (Alonso, Zaidi, Grundke‐Iqbal, & Iqbal, 1994). Here, MAPT is linked to Alzheimer disease.